[Federal Register Volume 84, Number 207 (Friday, October 25, 2019)]
[Notices]
[Pages 57450-57451]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23251]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2018-N-3163; FDA-2012-D-0429; FDA-2012-D-0049; FDA-
2018-N-3031; FDA-2011-D-0125; FDA-2018-N-4428; FDA-2012-N-0560; FDA-
2010-N-0414; FDA-2012-N-1203; and FDA-2019-N-0430]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is publishing
a list of information collections that have been approved by the Office
of Management and Budget (OMB) under the Paperwork Reduction Act of
1995 (PRA).
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
[email protected].
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Physician Interpretation of Information 0910-0875 9/30/2021
About Prescription Drugs in Scientific
Publications Versus Promotional Pieces.
Guidance on Meetings with Industry and 0910-0731 8/31/2022
Investigators on the Research and
Development of Tobacco Products........
[[Page 57451]]
Reporting Harmful and Potentially 0910-0732 8/31/2022
Harmful Constituents in Tobacco
Products and Tobacco Smoke Under the
Federal Food, Drug, and Cosmetic Act...
Tobacco Products, User Fees, 0910-0749 8/31/2022
Requirements for the Submission of Data
Needed to Calculate User Fees for
Domestic Manufacturers and Importers of
Tobacco................................
Guidance for Industry on Establishing 0910-0775 8/31/2022
That a Tobacco Product Was Commercially
Marketed in the United States as of....
February 15, 2007.......................
Medicated Feed Mill License Application. 0910-0337 9/30/2022
Guidance on Informed Consent for In 0910-0582 9/30/2022
Vitro Diagnostic Studies Using Leftover
Human Specimens That Are Not
Individually Identifiable..............
Manufactured Food Regulatory Program 0910-0601 9/30/2022
Standards..............................
Information to Accompany Humanitarian 0910-0661 9/30/2022
Device Exemption Applications and
Annual Distribution Number Reporting
Requirements...........................
Generic Clearance for Quick Turnaround 0910-0876 9/30/2022
Testing of Communication Effectiveness.
------------------------------------------------------------------------
Dated: October 17, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-23251 Filed 10-24-19; 8:45 am]
BILLING CODE 4164-01-P